{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:08:00Z","timestamp":1783577280771,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T00:00:00Z","timestamp":1525046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-11-2-0133"],"award-info":[{"award-number":["W81XWH-11-2-0133"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["TL1TR001858"],"award-info":[{"award-number":["TL1TR001858"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10620-018-5056-x","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T10:24:38Z","timestamp":1525083878000},"page":"2729-2739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3974-9564","authenticated-orcid":false,"given":"Alyce","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Click","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ramos-Rivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis E.","family":"Koutroubakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana G.","family":"Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Barrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Binion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,30]]},"reference":[{"key":"5056_CR1","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"19","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;19:2066\u20132078.","journal-title":"N Engl J Med"},{"key":"5056_CR2","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","volume":"24","author":"G Trikudanathan","year":"2012","unstructured":"Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;24:2333\u20132349.","journal-title":"Drugs"},{"key":"5056_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.det.2015.03.007","volume":"33","author":"JW Hagen","year":"2015","unstructured":"Hagen JW, Swoger JM, Grandinetti LM. Cutaneous manifestations of crohn disease. Dermatol Clin. 2015;33:417\u2013431.","journal-title":"Dermatol Clin"},{"key":"5056_CR4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR, et al. The first european evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10:239\u2013254.","journal-title":"J Crohns Colitis"},{"key":"5056_CR5","first-page":"13","volume":"6","author":"BL Huang","year":"2012","unstructured":"Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol. 2012;6:13.","journal-title":"Front Physiol"},{"key":"5056_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.MIB.0000436959.62286.f9","volume":"20","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014;20:213\u2013227.","journal-title":"Inflamm Bowel Dis"},{"key":"5056_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/01.MIB.0000442011.60285.68","volume":"20","author":"A Weizman","year":"2014","unstructured":"Weizman A, Huang B, Berel D, et al. Clinical, serologic, and genetic factors associated with pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease patients. Inflamm Bowel Dis. 2014;20:525\u2013533.","journal-title":"Inflamm Bowel Dis"},{"key":"5056_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M15-0729","volume":"5","author":"I Cleynen","year":"2016","unstructured":"Cleynen I, Van Moerkercke W, Billiet T, et al. Characteristics of skin lesions associated with anti-tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study. Ann Intern Med. 2016;5:10\u201322.","journal-title":"Ann Intern Med"},{"key":"5056_CR9","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/ajg.2009.760","volume":"105","author":"N Pedersen","year":"2010","unstructured":"Pedersen N, Duricova D, Elkjaer M, Gamborg M, Munkholm P, Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010;105:1480\u20131487.","journal-title":"Am J Gastroenterol"},{"key":"5056_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cgh.2013.05.022","volume":"12","author":"MD Kappelman","year":"2014","unstructured":"Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30\u00a0years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12:e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5056_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cgh.2013.04.033","volume":"12","author":"S Singh","year":"2014","unstructured":"Singh S, Nagpal SJ, Murad MH, et al. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:210\u2013218.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5056_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1053\/j.gastro.2012.05.004","volume":"143","author":"MD Long","year":"2012","unstructured":"Long MD, Martin CF, Pipkin CA, Herfarth HH, Sandler RS, Kappelman MD. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology. 2012;143:e1.","journal-title":"Gastroenterology"},{"key":"5056_CR13","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1136\/ard.2010.149419","volume":"70","author":"X Mariette","year":"2011","unstructured":"Mariette X, Matucci-Cerinic M, Pavelka K, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis. Ann Rheum Dis. 2011;70:1895\u20131904.","journal-title":"Ann Rheum Dis"},{"key":"5056_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.15403\/jgld.2014.1121.233.mrmk","volume":"23","author":"MR McKenna","year":"2014","unstructured":"McKenna MR, Stobaugh DJ, Deepak P. Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-\u03b1 inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System. J Gastrointestin Liver Dis. 2014;23:267\u2013271.","journal-title":"J Gastrointestin Liver Dis"},{"key":"5056_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ajg.2016.537","volume":"112","author":"FA Farraye","year":"2017","unstructured":"Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112:241\u2013258.","journal-title":"Am J Gastroenterol"},{"key":"5056_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","volume":"40","author":"P Jensen","year":"1999","unstructured":"Jensen P, Hansen S, M\u00f8ller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40:177\u2013186.","journal-title":"J Am Acad Dermatol"},{"key":"5056_CR17","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/ajg.2014.298","volume":"109","author":"AM Abbas","year":"2014","unstructured":"Abbas AM, Almukhtar RM, Loftus EV, Lichtenstein GR, Khan N. Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. Am J Gastroenterol. 2014;109:1781\u20131793.","journal-title":"Am J Gastroenterol"},{"key":"5056_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamadermatol.2015.3029","volume":"152","author":"FI Scott","year":"2016","unstructured":"Scott FI, Mamtani R, Brensinger CM, et al. Risk of nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer. JAMA Dermatol. 2016;152:164\u2013172.","journal-title":"JAMA Dermatol"},{"key":"5056_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14105","author":"J Clowry","year":"2017","unstructured":"Clowry J, Sheridan J, Healy R, et al. Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study. J Eur Acad Dermatol Venereol. 2017. \n                    https:\/\/doi.org\/10.1111\/jdv.14105\n                    \n                  .","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5056_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.cgh.2009.11.024","volume":"8","author":"MD Long","year":"2010","unstructured":"Long MD, Herfarth HH, Pipkin CA, Porter CQ, Sandler RS, Kappelman MD. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2010;8:268\u2013274.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5056_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ypmed.2004.04.022","volume":"39","author":"M Saraiya","year":"2004","unstructured":"Saraiya M, Hall HI, Thompson T, et al. Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med. 2004;39:308\u2013314.","journal-title":"Prev Med"},{"key":"5056_CR22","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.amjmed.2009.10.014","volume":"123","author":"EJ Coups","year":"2010","unstructured":"Coups EJ, Geller AC, Weinstock MA, Heckman CJ, Manne SL. Prevalence and correlates of skin cancer screening among middle-aged and older white adults in the United States. Am J Med. 2010;123:439\u2013445.","journal-title":"Am J Med"},{"key":"5056_CR23","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1007\/s10620-016-4278-z","volume":"61","author":"AJ Anderson","year":"2016","unstructured":"Anderson AJ, Click B, Ramos-Rivers C, et al. Development of an inflammatory bowel disease research registry derived from observational electronic health record data for comprehensive clinical phenotyping. Dig Dis Sci. 2016;61:3236\u20133245.","journal-title":"Dig Dis Sci"},{"key":"5056_CR24","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol. 2005;19:5A\u201336A.","journal-title":"Can J Gastroenterol"},{"key":"5056_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"8","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. The Lancet. 1980;8:514.","journal-title":"The Lancet"},{"key":"5056_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","volume":"1","author":"RA Kozarek","year":"1989","unstructured":"Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med. 1989;1:353\u2013356.","journal-title":"Ann Intern Med"},{"key":"5056_CR27","first-page":"1571","volume":"91","author":"EJ Irvine","year":"1996","unstructured":"Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571\u20131578.","journal-title":"Am J Gastroenterol"},{"key":"5056_CR28","unstructured":"Crohn\u2019s and Colitis Foundation Professional Education Committee Sub Group: CCFA Health Maintenance Checklist for Adult IBD Patients 2017."},{"key":"5056_CR29","doi-asserted-by":"publisher","first-page":"e4012","DOI":"10.1097\/MD.0000000000004012","volume":"95","author":"N Pandey","year":"2016","unstructured":"Pandey N, Herrera HH, Johnson CM, MacCarthy AA, Copeland LA. Preventative care for patients with inflammatory bowel disease in the Veterans Health Administration. Medicine. 2016;95:e4012.","journal-title":"Medicine"},{"key":"5056_CR30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cgh.2008.10.007","volume":"7","author":"MD Long","year":"2009","unstructured":"Long MD, Porter CQ, Sandler RS, Kappelman MD. Suboptimal rates of cervical testing among women with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2009;7:549\u2013553.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5056_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2007.02.010","volume":"57","author":"MS Goldberg","year":"2007","unstructured":"Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma\/Skin Cancer Screening Program experience 2001\u20132005. J Am Acad Dermatol. 2007;57:60\u201366.","journal-title":"J Am Acad Dermatol"},{"key":"5056_CR32","first-page":"513","volume":"143","author":"B Lindel\u00f6f","year":"2000","unstructured":"Lindel\u00f6f B, Sigurgeirsson B, G\u00e4bel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513\u2013519.","journal-title":"Br J Dermatol"},{"key":"5056_CR33","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/jid.2015.312","volume":"135","author":"HA Robbins","year":"2015","unstructured":"Robbins HA, Clarke CA, Arron ST, et al. Melanoma Risk and survival among organ transplant recipients. J Invest Dermatol. 2015;135:2657\u20132665.","journal-title":"J Invest Dermatol"},{"key":"5056_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0190-9622(99)70149-0","volume":"40","author":"EW Cowen","year":"1999","unstructured":"Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol. 1999;40:697\u2013701.","journal-title":"J Am Acad Dermatol"},{"key":"5056_CR35","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/TP.0000000000000084","volume":"97","author":"FR Ali","year":"2014","unstructured":"Ali FR, Samarasinghe V, Russell SA, Lear JT. Increasing capacity for skin surveillance in a transplant review clinic. Transplantation. 2014;97:e48\u2013e50.","journal-title":"Transplantation"},{"key":"5056_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/ctr.12490","volume":"29","author":"A Lloyd","year":"2015","unstructured":"Lloyd A, Klintmalm G, Qin H, Menter A. Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations. Clin Transplant. 2015;29:110\u2013117.","journal-title":"Clin Transplant"},{"key":"5056_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1440-1797.2011.01549.x","volume":"17","author":"NC Williams","year":"2012","unstructured":"Williams NC, Tong A, Howard K, Chapman JR, Craig JC, Wong G. Knowledge, beliefs and attitudes of kidney transplant recipients regarding their risk of cancer. Nephrology (Carlton). 2012;17:300\u2013306.","journal-title":"Nephrology (Carlton)"},{"key":"5056_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.canep.2010.07.002","volume":"35","author":"HC Wisgerhof","year":"2011","unstructured":"Wisgerhof HC, van der Geest LG, de Fijter JW, et al. Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol. 2011;35:105\u2013111.","journal-title":"Cancer Epidemiol"},{"key":"5056_CR39","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/ajg.2013.249","volume":"108","author":"T Jess","year":"2013","unstructured":"Jess T, Horv\u00e1th-Puh\u00f3 E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study. Am J Gastroenterol. 2013;108:1869\u20131876.","journal-title":"Am J Gastroenterol"},{"key":"5056_CR40","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/1097-0142(197410)34:4<1333::AID-CNCR2820340447>3.0.CO;2-A","volume":"34","author":"J Scotto","year":"1974","unstructured":"Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer. 1974;34:1333\u20131338.","journal-title":"Cancer"},{"key":"5056_CR41","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jaad.2013.10.060","volume":"70","author":"MY Cheng","year":"2014","unstructured":"Cheng MY, Moreau JF, McGuire ST, Ho J, Ferris LK. Melanoma depth in patients with an established dermatologist. J Am Acad Dermatol. 2014;70:841\u2013846.","journal-title":"J Am Acad Dermatol"},{"key":"5056_CR42","first-page":"564","volume":"41","author":"RS Kirsner","year":"1999","unstructured":"Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol. 1999;41:564\u2013566.","journal-title":"J Am Acad Dermatol"},{"key":"5056_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1046\/j.1525-1497.2001.00526.x","volume":"16","author":"SA Oliveria","year":"2001","unstructured":"Oliveria SA, Christos PJ, Marghoob AA, Halpern AC. Skin cancer screening and prevention in the primary care setting: national ambulatory medical care survey 1997. J Gen Intern Med. 2001;16:297\u2013301.","journal-title":"J Gen Intern Med"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5056-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T14:19:15Z","timestamp":1589725155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5056-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,30]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["5056"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5056-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,30]]},"assertion":[{"value":"1 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Alyce Anderson, Laura K. Ferris, Benjamin Click, Claudia Ramos-Rivers, Ioannis E. Koutroubakis, Jana G. Hashash, Michael Dunn, Arthur Barrie, Marc Schwartz, Miguel Regueiro, and David G. Binion declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}